Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04499950 · ClinicalTrials.gov registry record · Phase 2
Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study
A Phase 2 study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT04499950 is a Phase 2 study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 53 participants.
The verdict
NCT04499950, a Phase 2 study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
This is a single arm phase II study designed to determine the effects of pharmacotherapy and a remote behavioral weight loss intervention on weight loss in breast cancer survivors who are overweight or obese, and the impact of successful weight loss on serum biomarkers and gut microbiome.
Interventions
- BEHAVIORAL Behavioral Weight Loss
- DRUG Contrave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2024-01-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04499950
The ClinicalTrials.gov registry entry for NCT04499950 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral Weight Loss is the first listed.
NCT04499950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04499950 about?
NCT04499950 is a clinical study titled "Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study". This is a single arm phase II study designed to determine the effects of pharmacotherapy and a remote behavioral weight loss intervention on weight loss in breast cancer survivors who are overweight or obese, and the impact of successful weight loss on serum biomarkers and gut microbiome.
What is the current status of trial NCT04499950?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2021-02-08. Estimated completion is 2024-01-10.
What interventions are being tested in trial NCT04499950?
The interventions under investigation include: Behavioral Weight Loss (BEHAVIORAL), Contrave (DRUG).
Who is sponsoring clinical trial NCT04499950?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.